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ase and Cmr5, respectively. Our results suggest that Cmr2 possesses novel enzymatic activity that
remains to be elucidated.
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Clustered regularly interspaced short palindromic repeat
(CRIPSR) loci and CRIPSR-associated (Cas) proteins constitute an
adaptive and inheritable immunity system against the invasion
of viruses and conjugative plasmids in prokaryotes (see reviews
[1–6]). This defense system is widespread and present in approxi-
mately 40% of bacteria and 81% of archaea. CRIPSR loci are com-
posed of arrays of direct repeats (23–47 bp) separated by
variable DNA sequences called spacers (30–40 bp) that are derived
from invader genetic elements [7–9]. Approximately 50 cas gene
families located near CRISPR loci in various organisms have been
documented and are proposed to be involved in various steps in
CRISPR-based defense pathways [5,10–12]. According to an up-
dated classiﬁcation, CRISPR-Cas systems are grouped into three
distinct types (I, II and III) and ten subtypes [5]. Each type and sub-
type is characterized by the presence of a signature Cas protein; for
example, Cas3, Cas9 and Cas10 are the signature proteins for
types I, II and III, respectively.
The CRISPR-based defense system generally works in three
phases. In the ﬁrst adaption phase, a short sequence (proto-spacer)chemical Societies. Published by E
ced short palindromic repeat;
eotide cyclase; AC, adenylate
s-(30–50)-cyclic di-guanosinefrom invading DNAs is acquired and integrated into the 50 leader-
end of CRISPR arrays as a new repeat-spacer unit [13]. Cas1 and
Cas2, universal to all CRISPR-Cas systems, are likely involved in
spacer acquisition [14,15]. In the second expression phase, CPISPR
arrays are transcribed into precursor CRISPR RNAs (pre-crRNAs),
which are then cleaved at repeat regions by site-speciﬁc endonu-
cleases (Cas6 and its variants) into small crRNAs [16–23]. In the
third interference stage, the guide crRNAs associate with Cas pro-
teins to form effector complexes that neutralize matching DNA
or RNA. Genetic and biochemical evidence has indicated that
DNA is targeted in several organisms [22,24,25]. The Escherichia
coli Cascade (CRISPR-associated complex for antiviral defense)
complex (subtype I-E) is the best-studied DNA-targeting effector
complex that binds complementary DNA and induces its degrada-
tion by Cas3 [22,26–28].
The only known RNA-targeting effector complex has been puri-
ﬁed from Pyrococcus furiosus and consists of a crRNA and proteins
Cmr1, Cmr2 (Cas10), Cmr3, Cmr4, Cmr5 and Cmr6 [29]. These com-
ponent proteins belong to the RAMP (repeat-associated mysterious
protein) module [11], which was renamed the type III-B CRISPR-
Cas system [5]. P. furiosus crRNAs are either 39 or 45 nucleotides
(nt) in length, and the two variants share a 8-nt 50-handle derived
from the repeat sequence but differ in their 30-ends [20,29].
The crRNA–Cmr complex cleaves complementary RNA at a ﬁxed
14-nt distance from the 30-end of crRNA [29]. The structural
organization of the Cmr complex and the function of its individual
components are unknown.lsevier B.V. All rights reserved.
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for the RNA-guided RNA cleavage activity [29]. Cmr2 is homolo-
gous to Cms1 in subtype III-B and to unclassiﬁed Csx11 [30]; these
related proteins were recently renamed Cas10, which is the signa-
ture protein for type III CRISPR-Cas systems [5]. The signature pro-
tein of subtype I-D, Cas10d, is degenerate to Cas10. Moreover,
Cas10 has been proposed to play an important role in the evolution
of most CRISPR-Cas systems [30]. Cas10 has been denoted CRISPR
polymerase because of its homology to the palm domain of nucle-
otide cyclases (NCs) and DNA polymerases [31]. Despite the impor-
tant role of Cmr2 for the functioning of the Cmr complex and the
evolution of the CRISPR-Cas systems, its structure and function re-
main unknown.
In this study, we determined the crystal structure of Cmr2, the
ﬁrst structure of a member of the Cas10 superfamily. The major
part of Cmr2 structure resembles an adenylate cyclase dimer and
includes one cyclase domain with a set of putative catalytic resi-
dues and another highly deviant cyclase domain. Additionally,
Cmr2 has two helical bundle domains that are similar to the thumb
domain of A-family DNA polymerase and Cmr5, respectively. The
crystal structure strongly suggests that Cmr2 is an enzyme that
acts on nucleotides or nucleic acids.2. Materials and methods
2.1. Gene cloning, protein expression and puriﬁcation
The DNA sequence of Cmr2 (residues 195–871) was PCR-ampli-
ﬁed from genomic DNA of P. furiosus DSM 3638 and cloned into a
pET28a vector with a C-terminal His6-tag. The recombinant protein
was expressed in E. coli BL21 (DE3) strains in LB broth containing
50 lg/ml of kanamycin. The cells were grown to an OD600 of 0.7,
and protein expression was induced with 0.3 mM isopropyl-b-D-
thiogalactopyranoside for 16 h at 18 C. The cells were pelleted,
resuspended in buffer A (20 mM sodium phosphate pH 7.0,
500 mM sodium chloride) supplemented with 0.1 mM phenyl-
methylsulfonyl ﬂuoride, and then disrupted in a high-pressure
JN-3000 PLUS cell disruptor (JNBIO). After clariﬁcation by centrifu-
gation, the supernatant was heated at 75 C for 15 min. The clari-
ﬁed supernatant was supplemented with 20 mM imidazole and
applied to a 5-ml HisTrap column (GE Healthcare). The column
was washed with 50 ml of 50 mM imidazole in buffer A and the
protein was eluted with 500 mM imidazole in buffer A. Fractions
containing the target protein were pooled, concentrated to 1.5 ml
and further puriﬁed by gel ﬁltration with a Superdex S200 16/60
column (GE Healthcare) equilibrated in buffer B (20 mM HEPES-
Na pH 7.0 and 150 mM NaCl). The protein was concentrated to
30 mg/ml by an ultraﬁltration device and stored at 80 C. The
protein was labeled with selenomethionine in M9 medium by
blocking methionine biosynthesis [32]. The Se-labeled protein
was puriﬁed in the same way as the unlabeled protein except that
the protein solution was supplemented with 2 mM dithiothreitol
(DTT) after the HisTrap elution step.
2.2. Crystallization and data collection
Native and Se-labeled Cmr2 (195–871) were crystallized at
20 C by the hanging drop vapor diffusion method with a mixture
of 1 ll of protein solution (30 mg/ml, 20 mM HEPES-Na pH 7.0,
150 mM NaCl) and 1 ll of reservoir solution (0.1 M Tris–Cl pH
8.5, 33% PEG 400, 0.2 M sodium citrate). The crystals were directly
frozen in liquid nitrogen without additional cryoprotection. The
native and selenium derivative datasets were collected at 100 K
at the Shanghai Synchrotron Radiation Facility beamline BL17U
and processed with the HKL package [33]. The crystals belong tospace group P212121 with unit cell dimensions of a = 73.1 Å,
b = 87.0 Å and c = 137.7 Å. The asymmetric unit contains one mol-
ecule of Cmr2.2.3. Structural determination
The crystal structure was determined by single-wavelength
anomalous diffraction using a Se derivative dataset collected at
the Se-peak wavelength to 3.6 Å resolution. Eight heavy atoms,
including seven of a total ten Se atoms and one zinc atom, were
identiﬁed with SHELXD [34]. Phases were calculated and solvent
modiﬁed using SHARP [35]. The initial experimental electron den-
sity map was used to build approximately 50% of total residues
including a complete D3 domain. The sequence register was deter-
mined based on the positions of seven visible Se-Met residues and
bulky side chains. The phases from partial structural models were
combined with the experimental phases during density modiﬁca-
tion to calculate new electron density maps, which showed im-
proved quality and allowed for building 83% of the residues in
the ﬁnal model. The model was built in COOT [36] and reﬁned in
Refmac [37] and Phenix [38]. The current model comprises Cmr2
residues 205–340, 349–375, 417–435, 446–448, 451–537, 545–
613, 638–698, 707–780, 786–818 and 824–871 and 1 zinc ion.
RAMPAGE analysis showed that 90.5% of the residues are in most
favored regions, 8.9% in allowed regions and 0.6% in outlier regions.
Structural ﬁgures were generated with PyMOL [39]. The coordi-
nates and structural factors have been deposited in the Protein
Data Bank with accession number 4DOZ.3. Results and discussion
3.1. Structure determination and overall structure
We constructed, puriﬁed and crystallized a large fragment of P.
furiosus Cmr2 (residues 195–871, hereafter referred to as Cmr2)
that lacks the N-terminal putative HD nuclease domain (Fig. 1A).
The HD domain is absent in some Cmr2 and Csm1 homologs. The
crystal belonged to space group P212121 with one Cmr2 molecule
in the asymmetric unit. The structure was solved by Se-phasing
and reﬁned to an Rwork/Rfree of 0.245/0.313 at 3.1 Å resolution
(Table 1, Fig. 2A). Many peripheral structural elements displayed
weak electron density due to crystallographic disorder or intrinsic
ﬂexibility. In the current model, 17% of the residues were not
modeled due to poor or missing electron density.
The Cmr2 structure displays a triangle shape with overall
dimensions of 35 Å  68 Å  87 Å (Fig. 2B). The structure can be
divided into four domains: D1 (residues 205–502), D2 (residues
503–592), D3 (residues 593–764) and D4 (residues 765–871)
(Fig. 2C–G). The D3 domain is located in the center of the structure
and contacts the other three domains in three directions. We
searched the Protein Data Bank for structural homologs of the four
individual domains of Cmr2 using the DALI server [40].3.2. Cmr2 D1 and D3 are structurally similar to class III nucleotide
cyclases
The central D3 domain consists of a mixed 6-stranded b-sheet
ﬂanked by one or two a-helices on each side. D3 shares signiﬁcant
structural similarity with the catalytic domain of class III NCs (Z
score 10.98.6) and the palm domain of many nucleic acid poly-
merases such as Y- and A-family DNA polymerases that belong to
the RRM (RNA-recognition motif)-like fold (Z score 8.24) [41].
This is consistent with the previous sequence-based prediction
[31].
AB
Fig. 1. Domain organization and sequence conservation of Cmr2. (A) Domain diagram of Cmr2. The N-terminal HD nuclease domain was not included in the construct for
crystallization. (B) Sequence alignment of the Cas10 family. Sequences of 238 Cmr2 and Cms1 homologs were aligned using ClustalW. The sequences of Cmr2 from Pyrococcus
furiosus DSM 3638 (gi 18977501, Pf) and Csm1 from Mycobacterium tuberculosis CPHL_A (gi 289448484, Mt) are displayed. Residues conserved in 98%, 80% and 50% of all
aligned sequences are shaded in black, gray and light gray, respectively. The secondary structures observed in the Pf Cmr2 crystal structure are indicated on the top of the
alignment. Dashed lines indicate disordered regions.
Table 1
Data collection and reﬁnement statistics.
Crystal form Se-labeled Native
Data collection
Space group P212121 P212121
Cell dimensions
a, b, c (Å) 73.1, 87.0 137.7 73.4, 87.5, 137.1
a, b, c () 90, 90, 90 90, 90, 90
Wavelength (Å) 0.9794 0.9792
X-ray source SSRF BL17U SSRF BL17U
Resolution range (Å) 303.6 (3.663.6) 303.1 (3.153.1)
Unique reﬂections 10577 16512
Redundancy 13.3 (13.5) 6.7 (6.9)
I/r 16.5 (11.0) 13.6 (4.7)
Completeness (%) 99.8 (100) 99.2(100)
Rmerge 0.147 (0.538) 0.103 (0.482)
Structure reﬁnement
Resolution range (Å) 123.1 (3.1753.1)
No. reﬂections 15332
No. atoms 4522
Mean B factor (Å2) 110.7
Rwork 0.244 (0.365)
Rfree 0.313 (0.400)
Rmsd bond lengths (Å) 0.009
Rmsd bond angles () 1.283
Values for the data in the highest resolution bin are shown in parentheses.
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adenylate cyclases (ACs), guanylate cyclases (GCs) and diguanylate
cyclases (DGCs) [42]. ACs and GCs are closely related in structure
and synthesize the second messengers adenosine 30–50 cyclic
monophosphate (cAMP) and guanosine 30–50 cyclic monophos-phate (cGMP) from ATP and GTP, respectively. The cyclization
reaction involves an in-line nucleophilic attack of the 30-OH onto
the a-phosphate of the same nucleotide. DGCs condense two GTP
molecules into bis-(30–50)-cyclic di-guanosine monophosphate
(c-di-GMP), an important signaling molecule in prokaryotes. ACs
fold into a 7-stranded b-sheet packed by four a-helices (Fig. 2E)
and further dimerize into a wreath-like structure with two or
one active sites located in the central groove at the dimer interface
[43,44]. The palm domain of NCs, corresponding to the b1-a1-a2-
b2-b3-a3-b4 part of the AC structure, is conserved in many DNA
and RNA polymerases.
Structure alignment of D3 with CyaC from cyanobacterium Spi-
rulina platensis [45], a typical AC, yielded a root mean square devi-
ation (rmsd) of 1.225 Å (24 Ca pairs). However, strands b40 and b6
of CyaC are missing in Cmr2 D3.
Surprisingly, the N-terminal D1 domain also exhibits weak
resemblance with AC (Z score 3.4) (Fig. 2C). Nevertheless, D1 is
highly divergent from AC, contains many deletions and insertions
and is degenerate at the active site, which accounts for why the
structural homology is not recognizable from the sequence. Specif-
ically, D1 retains all four helices of AC but a much-abbreviated b-
sheet that is composed of three strands corresponding to strands
b3, b1 and b4 in the AC fold. In Cmr2 D1, strand b2 of AC is replaced
by helix a4 and several structured loops, and strands b5, b6 and b7
of AC are missing. Compared to AC, Cmr2 D1 contains several extra
structural elements, including an N-terminal helix a1, two helices
a6 and a7 inserted between a5 and b3 and a Zn-ribbon motif that
leads to the D2 domain (Fig. 2C).
In the Zn-ribbon, a mental ion, most likely a zinc ion, is sand-
wiched between the a8–a9 loop and the C-terminal part of helix
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Structure of D1. Structural elements that have counterparts in AC structures are green, the Zn-ribbon is yellow and others are white. Secondary structures and the N- and C-
termini are labeled. (D) Structure of D3. (E) Structure of one subunit of CyaC AC (PDB ID 1WC6) [45]. The secondary structure elements are labeled. The D1, D3 and CyaC
structures are aligned to similar orientation. (G) Structure of D2. (H) Structure alignment of Cmr2 D2 and the thumb domain of T7 DNA polymerase (PDB ID 1T7P) [51]. (I)
Structure of D4. (G) Structure alignment of Cmr2 D4 and Thermus thermophilus (Tt) Cmr5 (PDB ID 2ZOP) [46].
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C478 and C481 with a tetrahedral geometry. The presence of the
metal ion was conﬁrmed using an anomalous difference map cal-
culated with data acquired for Se-labeled crystals at the peak
wavelength of Se. Notably, these four Zn-coordinating cysteines
are conserved in only approximately half of Cmr2 and Csm1 pro-
teins (Fig. 1B), indicating that the Zn-ribbon motif is a variable
structural element.
3.3. Cmr2 D2 and D4 domains
The D2 domain forms a helical bundle that remotely resembles
the thumb domain of A-family DNA polymerases (Z score 3–4).
Both contain two antiparallel helices (a13 and a15 in Cmr2 D2)and an inter-helix region that folds back to one side of the helices
(Fig. 2G–H). The thumb domain interacts with the primer–
template duplex in polymerases. However, the functional implica-
tion of structural resemblance between Cmr2 D2 and thumb
domains is unclear.
The D4 domain adopts a six-helix bundle (Fig. 2I), which is
homologous with structures of diverse functions, including the
anticodon binding domain of glutamyl-tRNA synthase (Z score
5.5). The most relevant hits are two structures of Cmr5, another
component in the Cmr complex, from Thermus thermophilus (PDB
ID 2ZOP, Z score 4.4) [46] and Archaeoglobus fulgidus (PDB ID
2OEB, Z score 4.1) (Fig. 2G). This structural homology suggests that
Cmr2 D4 and Cmr5 may perform a similar function or interact with
each other in the Cmr complex.
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Overall, Cmr2 and Csm1 proteins are fairly divergent in se-
quence. The highly (>80%) conserved residues are mainly distrib-
uted in the central D3 domain (Fig. 1B). The conserved buried
residues constitute the hydrophobic core, whereas the conserved
surface residues are primarily clustered around the nucleotide-
binding pocket analogous to that in NCs and polymerases
(Fig. 3A). This strongly suggests that Cmr2 is an active enzyme that
employs this pocket for substrate binding and catalysis. Based on
sequence conservation consideration, the candidate catalytic resi-
dues of Cmr2 include the invariant residues D600, D673, D674
and S711 and the highly conserved residues Q230, D602, Y669
and K744 (Figs. 1B and 3B).
Residues D600 and D673 correspond to two invariant acidic res-
idues at the active site of NCs and polymerases (Fig. 3C–H). These
enzymes all employ a two-metal-ion mechanism to catalyze phos-
phoryl transfer reactions [47,48]. The two acidic residues coordi-
nate two Mg2+ ions, generally referred to as ions A and B, which
are involved in substrate binding and activation. The conserved
conﬁguration of the two acidic residues suggests that the reaction
catalyzed by Cmr2 is likely dependent on a two-metal-ion
mechanism.
In addition to similar domain structures, Cmr2 and ACs are re-
lated at the quaternary structure level. ACs form obligatory dimers
because their active sites are located at the dimer interface and
formed by both subunits. The two cyclase domains of Cmr2 associ-
ate with each other with an extensive interface, which buries
1471 Å2 of solvent accessible area per subunit comparable to
1770 Å2 in the CyaC AC dimer [45], and in an orientation roughly
similar to that in AC dimers (Fig. 3C). However, the cyclase dimer
interface is signiﬁcantly different between Cmr2 and AC. In AC di-
mers, the N-terminal part of b1, the C-terminal part of b4 and b40
form a long arm wrapping around the other subunit, contributing
critically to the dimer interface; however, a similar arm is absent
in both cyclase domains of Cmr2. In terms of domain architecture,
Cmr2 is similar to mammalian membrane-bound ACs that contain
an active and an inactive cyclase domain in a single polypeptide
that form an intramolecular dimer.
In each active site of AC dimers, one subunit coordinates two
Mg2+ ions and the other subunit (denoted by prime) contributes
to substrate binding and transition state stabilization [45,48]. For
example, in CyaC, the conserved N1146 and R1150 residues within
helix a40 contact the ribose and phosphate moiety of the substrate
(Fig. 3D). By contrast, helix a8 in Cmr2 D1, the equivalent of CyaC
helix a40, is distant from the nucleotide-binding site and unlikely
binds the nucleotide. Moreover, Cmr2 D1 lacks the equivalent
b60–b70 loop of AC, which covers the nucleotide-binding site
(Fig. 3D). The substrate-binding pocket of Cmr2 is more open com-
pared to AC and may be able to accept large substrates.
The other predicted catalytic residues of Cmr2 are not con-
served in ACs and polymerases, but interestingly are conserved
in DGCs at three positions. First, Cmr2 is characterized by an
invariant tetrapeptide GGDD that constitutes a turn connecting
strands b5 and b6 in D3 (Figs. 1B and 3B), whereas DGCs contain
a signature GG(D/E)EF motif at the equivalent position (DGC is also
known as the GGDEF domain) [49]. Second, Cmr2 residues S711
and D602 interact with each other by forming side chain hydrogen
bonds. A similar interacting Ser-Asp pair is present in DGCs. Third,
the equivalent residue of Cmr2 K744 is conserved as a basic residue
in DGCs and contacts the c-phosphate of GTP [50]. The Cmr2-cat-
alyzed reaction may be more related to c-di-GMP formation than
single nucleotide cyclization.
However, Cmr2 is unlikely to synthesize c-di-GMP. The conden-
sation of two GTP molecules into c-di-GMP requires the formation
of two intermolecular 30–50 phosphodiester bonds. The catalyticdomain of DGC is monomeric at the resting state. During the con-
densation reaction, two GTP-load DGC domains are thought to be
aligned such that the 30-OH of each GTP can make a nucleophilic
attack on the a-phosphate of the other GTP [50]. However, such
a pre-catalysis state has not yet been captured in a crystal struc-
ture. In the Cmr2 structure, the active cyclase domain D3 already
associates with the degenerate D1 domain and hence is unlikely
to perform a reaction that requires two active sites and yields a
product with dyad symmetry.
Cmr2 proteins have been termed CRISPR polymerases due to
homology to the palm domain of polymerases [31]. However, com-
parison with DNA polymerase structures suggests that the Cmr2
structure is incompatible with a template-dependent polymerase
activity (Fig. 3G–H). All polymerases contain the thumb, palm
and ﬁngers domains that arrange like a right hand [47]. First,
Cmr2 apparently lacks an equivalent of the ﬁngers domain, which
makes important contacts with the incoming nucleotide and the
base to which it pairs. The D1 domain that constitutes one face
of the active site pocket might fulﬁll the role of ﬁngers domain in
binding the nucleotide. Alternatively, other components in the
Cmr complex might provide a ﬁngers domain in trans. Second,
Cmr2 D2 shows interesting resemblance with the thumb domain
of A-family DNA polymerases, but it is not in a competent position
to contact the primer–template. Last, Cmr2 D1 stands on the path
of the template strand and would occlude the template. These fea-
tures argue against that Cmr2 is a canonical template-dependent
polymerase, but suggest that Cmr2 may catalyze a phosphoryl
transfer reaction in a template-independent manner.
4. Conclusion
The structure of Cmr2 bears signiﬁcant similarity to dimeric cy-
clase structures with a likely enzymatically active and a second
highly degenerate cyclase domain that associate with each other.
The features of the active site suggest that Cmr2 catalyzes a phos-
phoryl transfer reaction that requires a 2-metal-ion mechanism,
but seems be distinct from the reactions that ACs, DGCs and DNA
polymerases catalyze. The exact substrate and catalyzed reaction
of Cmr2 remain to be elucidated.
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